#United States #New York #Kuehn Law #Investor Relations #INOVIO Pharmaceuticals

Kuehn Law Urges Investors of Inovio Pharmaceuticals to Act

Kuehn Law, PLLC, a law firm focusing on shareholder litigation, has initiated an investigation concerning potential breaches of fiduciary duties by certain executives and board members of Inovio Pharmaceuticals, Inc. (NASDAQ: INO). This inquiry stems from a federal securities lawsuit that alleges misrepresentation and failure to disclose critical information regarding the company's CELLECTRA device manufacturing processes.

Potential Misconduct by Inovio Executives

According to the lawsuit, insiders at Inovio Pharmaceuticals might have not only misstated but also concealed important facts about their product's manufacturing deficiencies. Key allegations include that the company is unlikely to submit the Biologics License Application (BLA) for INO-3107 to the FDA in the anticipated timeframe. Analysts suggest that those developments significantly undermine the product’s regulatory and commercial potential.

Specifically, it has been noted that:

• - Manufacturing for the CELLECTRA device was reportedly subpar.
• - Inovio is not prepared to file the INO-3107 BLA expectedly by the second half of 2024.
• - There is insufficient data to support INO-3107's candidacy for accelerated approval from the FDA, raising questions about its prospects.

The lawsuit argues that these oversights have led to inflated expectations regarding INO-3107's potential, which could have detrimental implications for investors.

Why Shareholders Should Act Now

Investors who acquired Inovio Pharmaceuticals shares before October 10, 2023, are particularly encouraged to reach out to Kuehn Law. The firm is offering a complimentary consultation to discuss the potential legal avenues available. Justin Kuehn, Esq. notes, "Your voice matters in ensuring the integrity of the financial markets. By getting involved, you not only protect your investment but also reinforce the principle of accountability in corporate governance."

Kuehn Law covers all associated costs in initiating legal proceedings, ensuring that shareholders do not bear the financial burden during this process. Given the potentially limited timeframe to assert their rights, the firm emphasizes the urgency of timely action. Affected shareholders can contact Justin Kuehn directly via email at [email protected] or by calling (833) 672-0814.

The Importance of Investor Participation

The involvement of investors is crucial for maintaining fairness and transparency within the financial market. Each participant’s voice contributes to promoting accountability among corporations and protecting their investments. Kuehn Law advocates for shareholder rights and provides a platform for them to make their voices Heard.

For further information, shareholders can visit the Kuehn Law website to learn about their rights and available legal options. The firm's commitment to ensuring fair treatment for its clients is at the forefront of their services.

Your investment. Your voice. Your future.™

In a time when corporate governance is under scrutiny, Kuehn Law’s ongoing investigation into Inovio Pharmaceuticals serves as a reminder that shareholders play a vital role in the financial landscape. Participating in legal actions not only safeguards personal investments but also fosters a healthy business environment where ethical practices prevail.